Investment28 Jan 2026, 04:29 pm
Cupid Limited Receives CE (EU IVDR) Certification for HIV 1&2 and Hepatitis B IVD Test Kits, Expanding Global Market Access in Diagnostics
AI Summary
Cupid Limited, a diversified Indian healthcare and consumer products company, has received CE (EU IVDR) Certification for two in-vitro diagnostic (IVD) products - the CupiKIT HIV 1&2 Antibody Test Kit and the CupiKIT Hepatitis B Surface Antigen (HBsAg) Test Kit. These certifications enable Cupid Limited to market the certified products across the European Economic Area (EEA) and other CE-recognized international markets, strengthening its global diagnostics business and expanding access to regulated international markets. The Company continues to focus on building a reliable and affordable diagnostics portfolio while scaling its presence across key global regions to address growing healthcare needs.
Key Highlights
- Cupid Limited receives CE (EU IVDR) Certification for two IVD products, HIV 1&2 and Hepatitis B Test Kits.
- Certifications enable Cupid Limited to market the products across the EEA and other CE-recognized international markets.
- These approvals expand Cupid Limited's access to regulated international markets and enhance its ability to participate in large-scale screening and public health programs.
- Cupid Limited continues to focus on building a reliable and affordable diagnostics portfolio.
- The Company is scaling its presence across key global regions to address growing healthcare needs.